Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mika Ala-Korpela

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
International Journal of Epidemiology|April 11, 2019
The culprit is the carrier, not the loads: cholesterol, triglycerides and apolipoprotein B in atherosclerosis and coronary heart diseaseMika Ala-Korpela
Expert Review of Molecular Diagnostics|November 21, 2007
Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic toolMika Ala-Korpela
International Journal of Epidemiology|November 23, 2022
The epidemiological quest for the role of vitamin D turned non-linear-and simply made senseMika Ala-Korpela
International Journal of Epidemiology|March 16, 2019
Commentary: Data-driven subgrouping in epidemiology and medicineMika Ala-Korpela
Clinical Chemistry|October 18, 2017
Objective Metabolomics ResearchMika Ala-Korpela
European Journal of Preventive Cardiology|August 13, 2016
Metabolomics in cardiovascular medicine: Not personalised, not diagnosticMika Ala-Korpela
Clinical Chemistry and Laboratory Medicine|November 21, 2007
Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnosticsMika Ala-Korpela
Clinical Chemistry|March 12, 2015
Serum Nuclear Magnetic Resonance Spectroscopy: One More Step toward Clinical UtilityMika Ala-Korpela
International Journal of Epidemiology|February 11, 2020
Commentary: The unbelievable impediment to understanding causality of risk factors: case prostate cancerPauli Ohukainen, Mika Ala-Korpela
International Journal of Epidemiology|January 9, 2022
Commentary: Polygenic risk for breast cancer: in search for potential clinical utilityTingting Wang, Mika Ala-Korpela
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
International Journal of Epidemiology|April 11, 2019
The culprit is the carrier, not the loads: cholesterol, triglycerides and apolipoprotein B in atherosclerosis and coronary heart diseaseMika Ala-Korpela
Expert Review of Molecular Diagnostics|November 21, 2007
Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic toolMika Ala-Korpela
International Journal of Epidemiology|November 23, 2022
The epidemiological quest for the role of vitamin D turned non-linear-and simply made senseMika Ala-Korpela
International Journal of Epidemiology|March 16, 2019
Commentary: Data-driven subgrouping in epidemiology and medicineMika Ala-Korpela
Clinical Chemistry|October 18, 2017
Objective Metabolomics ResearchMika Ala-Korpela
European Journal of Preventive Cardiology|August 13, 2016
Metabolomics in cardiovascular medicine: Not personalised, not diagnosticMika Ala-Korpela
Clinical Chemistry and Laboratory Medicine|November 21, 2007
Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnosticsMika Ala-Korpela
Clinical Chemistry|March 12, 2015
Serum Nuclear Magnetic Resonance Spectroscopy: One More Step toward Clinical UtilityMika Ala-Korpela
International Journal of Epidemiology|February 11, 2020
Commentary: The unbelievable impediment to understanding causality of risk factors: case prostate cancerPauli Ohukainen, Mika Ala-Korpela
International Journal of Epidemiology|January 9, 2022
Commentary: Polygenic risk for breast cancer: in search for potential clinical utilityTingting Wang, Mika Ala-Korpela
Pageof 23